Early-stage Companies:  We help early stage companies with product assessment and product-customer fit. We can advise on the operating requirements for differing payers and are experts in understanding how innovative products must work within administrative and clinical workflows. 


Investors:  Our experience in identifying and accelerating early-stage companies and requirements for market-entry with payers supports decision-making .  As for early-stage companies, determining of  the likelihood of  success of companies and products is informed by expertise in clinical workflows and administrative operations. 


Boards:  As a non-executive member we can serve companies and investors by objectively looking at the plans framed by the executive team. We can help formulate and oversee strategy by  providing constructive criticism and broader view of the external factors relevant to the business.